Nakashima S, Suganuma A, Sato M, Tohmatsu T, Nozawa Y
Department of Biochemistry, Gifu University School of Medicine, Japan.
J Immunol. 1989 Aug 15;143(4):1295-302.
Upon stimulation of human polymorphonuclear neutrophils with platelet-activating factor (PAF), arachidonic acid (AA) is released from membrane phospholipids. The mechanism for AA liberation, a key step in the synthesis of biologically active eicosanoids, was investigated. PAF was found to elicit an increase in the cytoplasmic level of free Ca2+ as monitored by fluorescent indicator fura 2. When [3H] AA-labeled neutrophils were exposed to PAF, the enhanced release of AA was observed with a concomitant decrease of radioactivity in phosphatidylinositol and phosphatidylcholine fractions. The inhibitors of phospholipase A2, mepacrine and 2-(p-amylcinnamoyl)-amino-4-chlorobenzoic acid, effectively suppressed the liberation of [3H]AA from phospholipids, indicating that liberation of AA is mainly catalyzed by the action of phospholipase A2. The extracellular Ca2+ is not required for AA release. However, intracellular Ca2+ antagonists, TMB-8 and high dose of quin 2/AM drastically reduced the liberation of AA induced by PAF, indicating that Ca2+ is an essential factor for phospholipase A2 activation. PAF raised the fluorescence of fura 2 at concentrations as low as 8 pM which reached a maximal level about 8 nM, whereas more than nM order concentrations of PAF was required for the detectable release of [3H]AA. Pretreatment of neutrophils with pertussis toxin resulted in complete abolition of AA liberation in response to PAF. However, the fura 2 response to PAF was not effectively inhibited by toxin treatment. In human neutrophil homogenate and membrane preparations, guanosine 5'-O-(thiotriphosphate) stimulated AA release and potentiated the action of PAF. Guanosine 5'-O-(thiodiphosphate) inhibited the effects of guanosine 5'-O-(thiotriphosphate). These results suggest several points: 1) PAF stimulates human polymorphonuclear neutrophils to liberate AA mainly by the action of phospholipase A2; 2) Ca2+ mobilization alone is not sufficient to stimulate AA release, although Ca2+ is the important factor for phospholipase A2 activation; and 3) a pertussis toxin-sensitive GTP-binding protein may be implicated in activation of phospholipase A2.
用血小板活化因子(PAF)刺激人多形核中性粒细胞后,花生四烯酸(AA)从膜磷脂中释放出来。对AA释放机制进行了研究,这是生物活性类二十烷酸合成中的关键步骤。通过荧光指示剂fura 2监测发现,PAF能使细胞质中游离Ca2+水平升高。当用[3H]AA标记的中性粒细胞暴露于PAF时,观察到AA释放增强,同时磷脂酰肌醇和磷脂酰胆碱组分中的放射性降低。磷脂酶A2抑制剂米帕林和2-(对戊基肉桂酰基)-氨基-4-氯苯甲酸能有效抑制[3H]AA从磷脂中的释放,表明AA的释放主要由磷脂酶A2的作用催化。AA释放不需要细胞外Ca2+。然而,细胞内Ca2+拮抗剂TMB-8和高剂量的喹啉2/AM能显著降低PAF诱导的AA释放,表明Ca2+是磷脂酶A2激活的必要因素。PAF在低至8 pM的浓度下就能提高fura 2的荧光,在约8 nM时达到最大值,而可检测到[3H]AA释放则需要超过nM级别的PAF浓度。用百日咳毒素预处理中性粒细胞会导致对PAF的AA释放完全消失。然而,毒素处理并不能有效抑制fura 2对PAF的反应。在人中性粒细胞匀浆和膜制剂中,鸟苷5'-O-(硫代三磷酸)刺激AA释放并增强PAF的作用。鸟苷5'-O-(硫代二磷酸)抑制鸟苷5'-O-(硫代三磷酸)的作用。这些结果表明几点:1)PAF主要通过磷脂酶A2的作用刺激人多形核中性粒细胞释放AA;2)尽管Ca2+是磷脂酶A2激活的重要因素,但仅Ca2+动员不足以刺激AA释放;3)一种对百日咳毒素敏感的GTP结合蛋白可能与磷脂酶A2的激活有关。